Dr. Marc S. Hoffmann
Claim this profileUniversity of Kansas Hospital-Westwood Cancer Center
Studies Lymphoma
Studies B-Cell Lymphoma
12 reported clinical trials
26 drugs studied
Area of expertise
1Lymphoma
13q positive
13q negative
12 positive
2B-Cell Lymphoma
Affiliated Hospitals
Clinical Trials Marc S. Hoffmann is currently running
Immunotherapy
for Hodgkin's Lymphoma
This trial is testing a new treatment called mosunetuzumab against the usual treatment, rituximab, for patients with a type of cancer called NLPHL. Both treatments help the immune system find and kill cancer cells by targeting a specific protein on these cells. The goal is to see if mosunetuzumab can improve survival better than rituximab.
Recruiting1 award Phase 2
Rituximab vs Mosunetuzumab
for Follicular Lymphoma
This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. It is not yet known if giving rituximab or mosunetuzumab works better in treating patients with follicular lymphoma with a low tumor burden.
Recruiting2 awards Phase 313 criteria
More about Marc S. Hoffmann
Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Marc S. Hoffmann has experience with
- Rituximab
- Obinutuzumab
- Mosunetuzumab
- Cyclophosphamide
- Doxorubicin
- CC-99282
Breakdown of trials Marc S. Hoffmann has run
Lymphoma
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Mantle Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc S. Hoffmann specialize in?
Marc S. Hoffmann focuses on Lymphoma and B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved 13q positive patients, or patients who are 13q negative.
Is Marc S. Hoffmann currently recruiting for clinical trials?
Yes, Marc S. Hoffmann is currently recruiting for 6 clinical trials in Westwood Kansas. If you're interested in participating, you should apply.
Are there any treatments that Marc S. Hoffmann has studied deeply?
Yes, Marc S. Hoffmann has studied treatments such as Rituximab, Obinutuzumab, Mosunetuzumab.
What is the best way to schedule an appointment with Marc S. Hoffmann?
Apply for one of the trials that Marc S. Hoffmann is conducting.
What is the office address of Marc S. Hoffmann?
The office of Marc S. Hoffmann is located at: University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas 66205 United States. This is the address for their practice at the University of Kansas Hospital-Westwood Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.